Globavend is trading at $1.05 (+5.00%), with no clear company-specific catalyst found for August 17, 2026.

  • Globavend’s August 15, 2026, filing was a procedural F-1 amendment removing an exhibit, not an earnings or operational announcement.
  • Broader markets were mixed: the Nasdaq rose 0.49% and the S&P 500 gained 0.12%.
  • The rise may reflect low-liquidity pre-market trading.